Search Results 1171-1180 of 16853 for Linaclotide

  1. Clinical Biochemistry & Immunology - Laboratory Medicine and Pathology

    Clinical Biochemistry & Immunology provides analysis of biological fluids or tissues for specific chemical constituents or physiologic processes.

  2. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  3. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  4. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  5. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  6. Neurology - Clinical trials

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  7. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  8. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  9. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  10. A Study Comparing X-396 (Ensartinib) to Crizotinib in Patients with ALK Positive Non-Small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of X-396 (ensartinib) versus crizotinib in patients who have ALK-positive non-small cell ...